Pavle Jeremic's guest appearances

Pavle Jeremic

Founders First

Science in Society

Machine Learning Engineered

Ben Smith

Shaughnessy Bishop-Stall

Nicole Avena

Richard Schwartz

Nick Friedman

John Flaherty

Radek Osmulski

Alex Watson

Shawn Wang

Elliot Roth

Larry Young

Ben Gardner

Zak Slayback

Charles Yang

Josh Albrecht

OwlTail

If you had to rank your favorite 3 superheroes, would Iron Man make your list? Have you ever wondered if there could one day be a real-life Tony Stark? This month’s guest, Pavle Jeremic, is trying to make that science fiction a reality. In this episode, you, along with Drew &amp; Liv, will learn how Jeremic and his team at Aether plan to use chemistry, biology, engineering, and artificial intelligence to develop a toolkit of molecular assemblers capable of synthesizing any desired arrangement of atoms.You can follow Drew &amp; Liv on Instagram @scienceinsociety to stay in the know on upcoming episodes, new content, and their ~nearly~ famous science shenanigans.

If you had to rank your favorite 3 superheroes, would Iron Man make your list? Have you ever wondered if there could one day be a real-life Tony Stark? This month’s guest, Pavle Jeremic, is trying to make that science fiction a reality. In this episode, you, along with Drew &amp; Liv, will learn how Jeremic and his team at Aether plan to use chemistry, biology, engineering, and artificial intelligence to develop a toolkit of molecular assemblers capable of synthesizing any desired arrangement of atoms. You can follow Drew &amp; Liv on Instagram <a href="https://www.instagram.com/scienceinsociety/" rel="nofollow" target="_blank">@scienceinsociety</a> to stay in the know on upcoming episodes, new content, and their ~nearly~ famous science shenanigans.

The Science of Nanotech with Pavle Jeremic

Pavle Jeremic is the founder and CEO of Aether Biomachines, one of the most exciting ML-powered startups I've come across. His mission is to solve scarcity and Aether is the first step towards that. He was recently featured in Forbes' 30 under 30 in Manufacturing and holds a B.S. in Biomolecular Engineering from UC Santa Cruz.Learn more:Aether BiomachinesEvery Thursday I send out the most useful things I’ve learned, curated specifically for the busy machine learning engineer. Sign up here: http://bitly.com/mle-newsletterFollow Charlie on Twitter: https://twitter.com/CharlieYouAISubscribe to ML Engineered: https://mlengineered.com/listenComments? Questions? Submit them here: http://bit.ly/mle-surveyTake the Giving What We Can Pledge: https://www.givingwhatwecan.org/Timestamps:02:45 Pavle Jeremic05:20 How Pavle was introduced to computer science and programming08:00 Solving scarcity from first principles23:20 How Aether contributes to the post-scarcity future29:30 What enzymatic reaction data looks like37:20 Using deep learning to figure out what enzymatic experiments to run next39:45 How Aether runs thousands of experiments at a time47:00 What the current bottleneck of the system is53:15 The evolution of ML models at Aether59:00 Gaps in existing ML infrastructure solutions01:03:30 Why Aether is releasing some of their data for a competition01:06:50 The upcoming roadmap for Aether01:09:30 Rapid fire questionsLinks:Founders First Interview - Making Alchemy RealDeepChemEngines of CreationRama Series

Pavle Jeremic is the founder and CEO of Aether Biomachines, one of the most exciting ML-powered startups I've come across. His mission is to solve scarcity and Aether is the first step towards that. He was recently featured in Forbes' 30 under 30 in Manufacturing and holds a B.S. in Biomolecular Engineering from UC Santa Cruz.Learn more:<a href="aetherbio.com" rel="noopener noreferrer nofollow" target="_blank">Aether Biomachines</a> Every Thursday I send out the most useful things I’ve learned, curated specifically for the busy machine learning engineer. Sign up here: <a href="http://bitly.com/mle-newsletter" rel="noopener noreferrer nofollow" target="_blank">http://bitly.com/mle-newsletter</a> Follow Charlie on Twitter: <a href="https://twitter.com/CharlieYouAI" rel="noopener noreferrer nofollow" target="_blank">https://twitter.com/CharlieYouAI</a>Subscribe to ML Engineered: <a href="https://mlengineered.com/listen" rel="noopener noreferrer nofollow" target="_blank">https://mlengineered.com/listen</a>Comments? Questions? Submit them here: <a href="http://bit.ly/mle-survey" rel="noopener noreferrer nofollow" target="_blank">http://bit.ly/mle-survey</a>Take the Giving What We Can Pledge: <a href="https://www.givingwhatwecan.org/" rel="noopener noreferrer nofollow" target="_blank">https://www.givingwhatwecan.org/</a> Timestamps:02:45 Pavle Jeremic05:20 How Pavle was introduced to computer science and programming08:00 Solving scarcity from first principles23:20 How Aether contributes to the post-scarcity future29:30 What enzymatic reaction data looks like37:20 Using deep learning to figure out what enzymatic experiments to run next39:45 How Aether runs thousands of experiments at a time47:00 What the current bottleneck of the system is53:15 The evolution of ML models at Aether59:00 Gaps in existing ML infrastructure solutions01:03:30 Why Aether is releasing some of their data for a competition01:06:50 The upcoming roadmap for Aether01:09:30 Rapid fire questions Links:<a href="https://podcasts.apple.com/us/podcast/4-making-alchemy-real-pavle-jeremic-aether-biomachines/id1498805236?i=1000465399648" rel="noopener noreferrer nofollow" target="_blank">Founders First Interview - Making Alchemy Real</a><a href="https://deepchem.io/" rel="noopener noreferrer nofollow" target="_blank">DeepChem</a><a href="https://en.wikipedia.org/wiki/Engines_of_Creation" rel="noopener noreferrer nofollow" target="_blank">Engines of Creation</a><a href="https://www.goodreads.com/series/49121-rama" rel="noopener noreferrer nofollow" target="_blank">Rama Series</a>

Building a Post-Scarcity Future using Machine Learning with Pavle Jeremic (Aether Bio)

Aether Biomachines

When 1517 Fund looks to invest in technology companies, one of our favorite questions is, “what’s to stop someone else from coming in and copying you?” Pavle Jeremic had an incredibly exciting answer to that question. His firm, Aether Biomachines, is approaching control of 50% of all enzymatic data on Earth. In short order, they expect to reach 90%. That means they’ll have a head start, and moat, on applying machine learning and neural networks to high potential information. Pavle envisions this fundamentally changing the future of biological manufacturing for chemicals, food, and more. He discusses all this with 1517 Fund’s Zak Slayback in this 50-minute conversation. Connect with Pavle &amp; Aether Biomachines aetherbio.com Connect with 1517 Fund https://www.1517fund.com/take-action

When 1517 Fund looks to invest in technology companies, one of our favorite questions is, “what’s to stop someone else from coming in and copying you?” Pavle Jeremic had an incredibly exciting answer to that question. His firm, Aether Biomachines, is approaching control of 50% of all enzymatic data on Earth. In short order, they expect to reach 90%. That means they’ll have a head start, and moat, on applying machine learning and neural networks to high potential information. Pavle envisions this fundamentally changing the future of biological manufacturing for chemicals, food, and more. He discusses all this with 1517 Fund’s Zak Slayback in this 50-minute conversation. Connect with Pavle &amp; Aether Biomachines <a href="http://aetherbio.com/" rel="nofollow" target="_blank">aetherbio.com</a> Connect with 1517 Fund <a href="https://www.1517fund.com/take-action" rel="nofollow" target="_blank">https://www.1517fund.com/take-action</a>

4. Making Alchemy Real with Pavle Jeremic (Aether Biomachines)